In8bio Financial Statements From 2010 to 2024

INAB Stock  USD 0.32  0  0.63%   
In8bio financial statements provide useful quarterly and yearly information to potential In8bio Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on In8bio financial statements helps investors assess In8bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting In8bio's valuation are summarized below:
Market Capitalization
23.2 M
Earnings Share
(0.74)
We have found one hundred twenty available fundamental measures for In8bio, which can be analyzed and compared to other ratios and to its peers in the sector. All investors should make sure to confirm all of In8bio latest market performance against the performance between 2010 and 2024 to make sure the company can sustain itself next year.
Check In8bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among In8bio's main balance sheet or income statement drivers, such as Net Interest Income of 0.0, Depreciation And Amortization of 1.9 M or Interest Expense of 1.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.74. In8bio financial statements analysis is a perfect complement when working with In8bio Valuation or Volatility modules.
  
Check out the analysis of In8bio Correlation against competitors.

In8bio Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets25.1 M33.7 M13.9 M
Slightly volatile
Total Current Liabilities3.1 M5.4 M1.6 M
Slightly volatile
Property Plant And Equipment NetM8.6 M2.6 M
Slightly volatile
Accounts Payable918.3 K924 K618.6 K
Slightly volatile
Cash18.3 M21.3 M10.6 M
Slightly volatile
Non Current Assets TotalM9.1 M2.6 M
Slightly volatile
Non Currrent Assets Other687.7 K511 K310.8 K
Slightly volatile
Other Assets855.2 K470.4 K337.9 K
Slightly volatile
Cash And Short Term Investments18.3 M21.3 M10.6 M
Slightly volatile
Net Receivables24 K27 K29.4 K
Slightly volatile
Common Stock Total Equity800900980
Slightly volatile
Common Stock Shares Outstanding21 M29.9 M12.3 M
Slightly volatile
Liabilities And Stockholders Equity25.1 M33.7 M13.9 M
Slightly volatile
Non Current Liabilities Total2.1 M3.4 M1.3 M
Slightly volatile
Inventory12 K13.5 K14.7 K
Slightly volatile
Other Current Assets2.8 M3.3 M1.2 M
Slightly volatile
Other Stockholder Equity122 M116.2 M26.4 M
Slightly volatile
Total Liabilities5.2 M8.8 M2.9 M
Slightly volatile
Property Plant And Equipment Gross10.3 M9.9 M2.8 M
Slightly volatile
Total Current Assets20.1 M24.6 M11.4 M
Slightly volatile
Capital Stock3.8 KK8.3 M
Pretty Stable
Net Working Capital17 M19.2 M9.8 M
Slightly volatile
Common Stock2.2 KK1.5 K
Slightly volatile
Property Plant Equipment3.4 M3.3 M1.3 M
Slightly volatile
Other Current Liabilities1.1 M1.4 M448.1 K
Slightly volatile
Short and Long Term Debt Total3.7 M4.9 M1.3 M
Slightly volatile
Other Liabilities13.6 K15.3 K16.7 K
Slightly volatile
Deferred Long Term LiabilitiesM2.2 M2.4 M
Slightly volatile
Short and Long Term Debt139.2 K156.6 K170.5 K
Slightly volatile
Short Term DebtMM730.7 K
Slightly volatile
Intangible Assets100.8 K113.4 K123.5 K
Slightly volatile

In8bio Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.9 M1.8 M415.7 K
Slightly volatile
Selling General Administrative7.8 M13.5 M4.1 M
Slightly volatile
Other Operating Expenses16.3 M30.3 M8.1 M
Slightly volatile
Research Development8.5 M16.8 MM
Slightly volatile
Total Operating Expenses16.3 M30.3 M8.1 M
Slightly volatile
Reconciled Depreciation2.6 M2.5 M537.7 K
Slightly volatile
Cost Of Revenue2.6 M2.5 M502.5 K
Slightly volatile
Selling And Marketing ExpensesM2.3 M2.5 M
Slightly volatile

In8bio Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation4.6 M4.4 MM
Slightly volatile
Begin Period Cash Flow14.6 M18.4 M6.3 M
Slightly volatile
Depreciation2.6 M2.5 M537.7 K
Slightly volatile
Capital Expenditures1.1 M600 K877.9 K
Pretty Stable
Total Cash From Financing Activities18.7 M27 M12.6 M
Slightly volatile
End Period Cash Flow18.4 M21.3 M10.6 M
Slightly volatile
Change To Netincome2.7 M2.5 M753.8 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation0.230.23995.268
Slightly volatile
Inventory Turnover5.125.766.272
Slightly volatile
Days Of Inventory On Hand45.6251.3355.8904
Slightly volatile
Payables Turnover2.842.70670.6065
Slightly volatile
Cash Per Share0.710.71260.8332
Very volatile
Days Payables Outstanding1281351.4 K
Slightly volatile
Income Quality1.030.77781.1546
Slightly volatile
Intangibles To Total Assets0.00310.00340.0037
Slightly volatile
Net Debt To EBITDA0.550.5751.9325
Slightly volatile
Current Ratio8.444.566110.0855
Slightly volatile
Graham Number2.94.34472.9179
Slightly volatile
Debt To Equity0.06370.06070.0204
Slightly volatile
Capex Per Share0.01910.02010.0913
Slightly volatile
Interest Debt Per Share0.02580.05070.0143
Slightly volatile
Debt To Assets0.04720.04490.016
Slightly volatile
Days Of Payables Outstanding1281351.4 K
Slightly volatile
Ebt Per Ebit1.111.141.0368
Pretty Stable
Total Debt To Capitalization0.06010.05720.0196
Slightly volatile
Debt Equity Ratio0.06370.06070.0204
Slightly volatile
Quick Ratio8.434.566110.0633
Slightly volatile
Net Income Per E B T0.770.870.9425
Slightly volatile
Cash Ratio3.753.94629.4901
Slightly volatile
Days Of Inventory Outstanding45.6251.3355.8904
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.221.02571.1983
Slightly volatile
Debt Ratio0.04720.04490.016
Slightly volatile

In8bio Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap63.1 M41.2 M76.1 M
Slightly volatile
Enterprise Value39.9 M24.8 M45 M
Slightly volatile

In8bio Fundamental Market Drivers

Cash And Short Term Investments21.3 M

In8bio Upcoming Events

4th of April 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About In8bio Financial Statements

In8bio stakeholders use historical fundamental indicators, such as In8bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although In8bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in In8bio's assets and liabilities are reflected in the revenues and expenses on In8bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in In8bio Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue2.5 M2.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether In8bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of In8bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of In8bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on In8bio Inc Stock:
Check out the analysis of In8bio Correlation against competitors.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. If investors know In8bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.74)
Return On Assets
(0.78)
Return On Equity
(1.80)
The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In8bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.